- Home
- CNSP vs NUWE Comparison
CNSP vs NUWE Comparison
Compare CNSP & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- NUWE
- Stock Information
- Founded
- CNSP 2017
- NUWE 1999
- Country
- CNSP United States
- NUWE United States
- Employees
- CNSP N/A
- NUWE N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNSP Health Care
- NUWE Health Care
- Exchange
- CNSP Nasdaq
- NUWE Nasdaq
- Market Cap
- CNSP 5.6M
- NUWE 3.9M
- IPO Year
- CNSP 2019
- NUWE N/A
- Fundamental
- Price
- CNSP $0.94
- NUWE $0.20
- Analyst Decision
- CNSP Hold
- NUWE Strong Buy
- Analyst Count
- CNSP 1
- NUWE 1
- Target Price
- CNSP N/A
- NUWE $17.00
- AVG Volume (30 Days)
- CNSP 213.4K
- NUWE 31.3M
- Earning Date
- CNSP 08-13-2025
- NUWE 08-12-2025
- Dividend Yield
- CNSP N/A
- NUWE N/A
- EPS Growth
- CNSP N/A
- NUWE N/A
- EPS
- CNSP N/A
- NUWE N/A
- Revenue
- CNSP N/A
- NUWE $8,787,000.00
- Revenue This Year
- CNSP N/A
- NUWE $6.53
- Revenue Next Year
- CNSP N/A
- NUWE $51.63
- P/E Ratio
- CNSP N/A
- NUWE N/A
- Revenue Growth
- CNSP N/A
- NUWE N/A
- 52 Week Low
- CNSP $0.73
- NUWE $0.19
- 52 Week High
- CNSP $148.00
- NUWE $5.84
- Technical
- Relative Strength Index (RSI)
- CNSP 47.19
- NUWE 23.88
- Support Level
- CNSP $0.73
- NUWE $0.21
- Resistance Level
- CNSP $1.03
- NUWE $0.24
- Average True Range (ATR)
- CNSP 0.08
- NUWE 0.03
- MACD
- CNSP 0.02
- NUWE 0.01
- Stochastic Oscillator
- CNSP 56.67
- NUWE 4.29
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.